respiratory disease Archieven - Innovation Origins

Targeted aftercare helps patients with severe cases of corona

Research carried out in Innsbruck, Austria has shown that patients suffering from the COVID-19 respiratory disease caused by the SARS-CoV-2 virus can benefit from long-term targeted aftercare.

EPO doping drug appears to ease severe cases of COVID-19

The doping drug EPO seems to ease severe corona cases. This is what researchers at the Max Planck Institute for Experimental Medicine in Göttingen, Germany, […]